ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

ClinicalTrials.gov ID: NCT06122779

Public ClinicalTrials.gov record NCT06122779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2A, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Study identification

NCT ID
NCT06122779
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
208 participants

Conditions and interventions

Conditions

Interventions

  • BMS-986435 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2023
Primary completion
Jul 2, 2026
Completion
Jul 2, 2026
Last update posted
May 7, 2026

2023 – 2026

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 Recruiting
Colorado Heart and Vascular - Lakewood Lakewood Colorado 80228-1710 Recruiting
Ascension St. Vincent's Riverside Hospital - PPDS Jacksonville Florida 32204-4748 Recruiting
Local Institution - 0003 Miami Florida 33133-4223 Active, not recruiting
University of Miami FL Miller School of Medicine -1120 NW 14th St Miami Florida 33136-2107 Recruiting
Local Institution - 0014 Atlanta Georgia 30322-1013 Withdrawn
Local Institution - 0048 Atlanta Georgia 30322-1013 Withdrawn
Bluhm Cardiovascular Institute of Northwestern Chicago Illinois 60611-5969 Recruiting
Chicago Medical Research, LLC - Hazel Crest Hazel Crest Illinois 60429-2196 Recruiting
Ascension Medical Group St. Vincent - Indianapolis Heart Care Indianapolis Indiana 46260-1992 Recruiting
Local Institution - 0045 Indianapolis Indiana 46260-1992 Withdrawn
St. Louis Heart and Vascular St Louis Missouri 63136-6111 Recruiting
Local Institution - 0043 St Louis Missouri 63136 Withdrawn
Local Institution - 0117 Hackensack New Jersey 07601-1915 Not yet recruiting
Capital Cardiology Associates Albany New York 12211 Recruiting
Local Institution - 0105 Brooklyn New York 11215 Not yet recruiting
Weill Cornell Medicine New York New York 10065-4805 Recruiting
University of Rochester Medical Center - PPDS Rochester New York 14618-2668 Recruiting
Rochester General Hospital Center for Clinical Research Rochester New York 14621 Recruiting
Laurelton Heart Specialist PC - MyClinical - PPDS Rosedale New York 11422-1320 Recruiting
Duke Cardiology Clinic - PPDS Durham North Carolina 27710-4000 Recruiting
Local Institution - 0058 Cincinnati Ohio 45242 Withdrawn
Local Institution - 0041 Oklahoma City Oklahoma 73135-2607 Withdrawn
South Oklahoma Heart Research Oklahoma City Oklahoma 73135-2607 Recruiting
Abington Memorial Hospital Abington Pennsylvania 19001 Recruiting
Tennessee Center for Clinical Trials Tullahoma Tennessee 37388-8260 Recruiting
Local Institution - 0104 Austin Texas 78756-4080 Not yet recruiting
University of Texas Southwestern Medical Center Dallas Texas 75390 Recruiting
Angiocardiac Care of Texas - PA - PPDS Houston Texas 77025-5253 Recruiting
Local Institution - 0051 Houston Texas 77025-5253 Withdrawn
Local Institution - 0066 Falls Church Virginia 22042-1262 Withdrawn

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06122779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06122779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →